Bharat Serum IPO – Review, Allotment Status, Subscription, Price, Date & more
Last Updated Date: Aug 31, 2023Bharat Serum IPO, this year would like to raise Rs 2000 crore by selling 30% stake through this IPO. Bharat Serum and Vaccines Limited is backed up by Kotak Private Equity Group that acquires round one fourth stake of the company. Also another company called as OrbiMed Advisor that holds 10% of the stake. This article provides the details about the Bharat Serum IPO size, Bharat Serum IPO object, background of the company, the investors and the financial performance of the company.
Bharat Serum IPO Review & Ratings
| Bharat Serum IPO Ratings & Review | |
| Criteria | Ratings |
| Industry Sentiments | 8.1/10 |
| Industry Ranking | 8.4/10 |
| Company Background | 8.0/10 |
| Company Reputation | 8.0/10 |
| Competitive Edge | 8.4/10 |
| Financial Statements | 8.1/10 |
| Popularity Index | 8.3/10 |
| Promoters Reputation | 8.4/10 |
| Retail Appetite | 8.1/10 |
| Top Brokers Review | 8.2/10 |
| Overall Ratings | 8.1/10 |
| Star Ratings | ★★★★☆ |
Summary of Bharat Serum IPO
They also develop various immunological products and kits that are used for drug delivery systems and molecular research and for the development of therapeutic products. Bharat Serum IPO to raise Rs 2000 crore by selling 30% stake through this IPO. The plant flotation may estimate round Rs 6,667 crore or it could be more, if the investors demand is higher. The company is targeting to release the IPO by mid of 2018-19. According to public forum, the company has marked the sale of around Rs 600 crore in the financial year 2015-16.
The promoters for this company may appoint investment bank Jefferies & Co. for this upcoming IPO. The lead managers of the IPO and the registrar of the IPO are yet to be disclosed. The details would be included herein shortly. The Chairman and Managing Director of the company is Mr Bharat V Daftary. The Vice Chairman and Co-Managing Director is Dr. Gautam V. Daftary. The Finance Director of the company is Mr. Nilesh R. Ganjwala.
Subscribe to Bharat Serum IPO – Fill up the Form Below
Bharat Serum IPO Date
The Bharat Serum IPO is expected to be in market before the end of this calendar year. The company initiated the talks, so the IPO is expected to be out soon.
Bharat Serum IPO Subscription
| Subscription | |
| Day 1 | X |
| Day 2 | X |
| Day 3 | X |
| Day 4 | X |
| Day 5 | X |
The details of shares being subscribed would be updated on a daily basis upon release of the IPO.
Bharat Serum IPO Allotment Status
The details of shares allotted against the subscription would be updated once the allotment process is completed. The details would be accordingly updated.
Bharat Serum IPO Price Band
The price offered under the IPO is generally decided during the book building process. The IPO price has not been released yet. The details would be shortly updated in this section.
Bharat Serum IPO Issue Size
The Bharat Serum IPO size is expected to be close to Rs. 2000 crores. However, this is just an indicative number and the actual number would be updated once the IPO details are finalized by the Company. Please revisit us for the latest updates.
Bharat Serum IPO Equity Share Offerings
The number of shares being sold off by the existing investors is not disclosed yet.
Open Free Demat Account Now!
Bharat Serum And Vaccines Limited – Company Overview
Bharat Serum and Vaccines Limited headquarter is located in Thane but the manufacturing facilities are in Ambernath and Ahmedabad (India). The company was established in the year 1971.
The company liaison offices are spread across different part of the world. Bharat Serum And Vaccines Limited is a Mumbai based company, ranked among the best pharma Companies and is well known for its biomedical products into 6 major divisions: Assisted Reproductive Technology, Gynecology, Nephrology & Haematology, Critical Care Emergency Medicine, Neurology and Urology.
Bharat Serum’s main aim is to research & develop and manufacture various kinds of pharmaceutical and biomedical products that belongs to the above 6 divisions.
They also develop various immunological products and kits that are used for drug delivery systems and molecular research and for the development of therapeutic products.
Key members of Bharat Serum And Vaccines Limited:
The Chairman and Managing Director of the company is Mr Bharat V Daftary.
The Vice Chairman and Co-Managing Director is Dr. Gautam V. Daftary (M.D.)
The Finance Director of the company is Mr. Nilesh R. Ganjwala.
Competitive Strengths of Bharat Serum And Vaccines Limited
Business strategy of Bharat Serum And Vaccines Limited
Bharat Serum And Vaccines Limited – Financial Statements
A summary of the financial position of the company is presented below:
(The details would be updated shortly)
Assets of the Company
| Assets (in INR & Millions) | |||||
| Mar’17 | Mar’16 | Mar’15 | Mar’14 | Mar’13 | |
| Non-Current Asset | |||||
| Current Asset | |||||
| Total Asset | |||||
The details would be updated shortly.
Revenue & PAT of the Company
| Revenue & Profits (in INR & Millions) | |||||
| Mar’17 | Mar’16 | Mar’15 | Mar’14 | Mar’13 | |
| Total Revenue | |||||
| Profit after Tax (PAT) | |||||
Earnings per Equity Share
| Earning per Equity Share (in INR) | |||||
| Mar’17 | Mar’16 | Mar’15 | Mar’14 | Mar’13 | |
| Basic | |||||
| Diluted | |||||
The details would be shortly updated herein and an analysis of the same would also be presented.
Bharat Serums And Vaccines Limited – Promoters
The details of the promoters would be shortly updated.
Promoter Interest in the company.
The details of the interest held by the promoters in the company would be updated in a few days.
Promoter Interest in property of the company
These details would be updated shortly.
Bharat Serum IPO Offer Details or Issue Details
| Offer | The offer is expected to be close to Rs 1000 crores. |
| Of which | |
| Issue reserved for the Market Makers | – |
| Net Issue to the public | – |
| Of which | |
| Allotment to retail investors | – |
| Allotment to other investors | – |
| Equity Shares outstanding prior to the offer | – |
| Equity Shares outstanding after the Offer | – |
Bharat Serum IPO Issue Object
Will be declared and updated soon.
Bharat Serums IPO – Basis of the Offer Price
The IPO offer price is determined by the company and the lead managers by market evaluation and book building process. The price is also influenced by various qualitative and quantitative factors. Some such factors are discussed below.
The qualitative factors relevant to decide the issue price:
- Established since long
- Has survived a few cycles of economies
- Collaboration with big brands
The quantitative factors relevant for the issue price are:
- Earning per share
- Price/earning ratio
- Return on Net Worth
- Net Asset Value – NAV per Equity Share
Bharat Serum IPO Lead Managers
| Lead Managers |
| To be updated shortly |
Bharat Serum IPO Registrar to offer
| Registrar to offer |
| To be updated shortly |
Bharat Serums IPO Review by Top 10 Stock Brokers
| Top Stock Brokers Review | Company Reputation | Competitive Edge | Financial Statement | Popularity Index | Promoters Reputation |
| Angel Broking | |||||
| Sharekhan | |||||
| Kotak Securities | |||||
| ICICI Direct | |||||
| IIFL | |||||
| Edelweiss | |||||
| Zerodha | |||||
| 5Paisa | |||||
| Karvy | |||||
| Motilal Oswal |
The ratings would be updated once the financials and the other details of the IPO are released.
Bharat Serum IPO Grey Market Premium
Grey market for Bharat Serum IPO would open 15 days before the release of the IPO.
Subscribe to Bharat Serum IPO – Fill up the Form Below
Bharat Serum IPO News
News 1 : Bharat Serum planning to release IPO to raise Rs 2,000 crore.
Market Guide
Featured Topics